When healthcare met digital health: the next chapter of pharmaphorumBack in 2009, when I was living in Windsor, I remember walking to the pub with my wife Share XWhen healthcare met digital health: the next chapter of pharmaphorumhttps://pharmaphorum.com/views-analysis-digital/when-healthcare-met-digital-health-the-next-chapter-of-pharmaphorum/
Has COVID-19 forever changed the way pharma does business?There’s no doubt that the COVID-19 pandemic has thrust digital engagement into the spotlight for the pharmaceutical industry Share XHas COVID-19 forever changed the way pharma does business?https://pharmaphorum.com/views-and-analysis/has-covid-19-forever-changed-the-way-pharma-does-business/
Patient-partnered drug discovery: vision or reality?pharmaphorum’s Paul Tunnah talks to Anthony Yanni, newly appointed senior vice president & global head of patient centricity, Share XPatient-partnered drug discovery: vision or reality?https://deep-dive.pharmaphorum.com/magazine/patient-engagement/astellas-patient-partnered-drug-discovery-vision-or-reality/
From narrow AI to broad AIAs director of global life sciences at IBM Watson Health, Christina Busmalis is well placed to know how Share XFrom narrow AI to broad AIhttps://deep-dive.pharmaphorum.com/magazine/digital-health/narrow-ai-broad-ai-ibm-watson-christina-busmalis/
Paul Tunnah named 4th most influential person in UK health techpharmaphorum’s founder Dr Paul Tunnah has been named the 4th most influential person in UK health tech by Share XPaul Tunnah named 4th most influential person in UK health techhttps://pharmaphorum.com/news/paul-tunnah-named-4th-most-influential-person-in-uk-health-tech/
How big pharma and startups can learn from each otherFrancesca Wuttke’s varied career has taken her from research roles to private equity and now to the role Share XHow big pharma and startups can learn from each otherhttps://deep-dive.pharmaphorum.com/magazine/digital-health/almriall-startups-francesca-wuttke-digital/
Where next for patient centricity in pharma?As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need Share XWhere next for patient centricity in pharma?https://pharmaphorum.com/views-analysis-patients/where-next-for-patient-centricity-in-pharma/
Comms from the ground upDavid Hunt’s career has taken him from painting Havas Lynx Group’s offices to running the agency, and now Share XComms from the ground uphttps://deep-dive.pharmaphorum.com/magazine/sales-and-marketing-2019/comms-from-the-ground-up-david-hunt-havas/
Does the big pharma monster need taming?Paul Tunnah reviews Hedley Rees’ ‘Taming the Big Pharma Monster: by Speaking Truth to Power’, which takes pharma Share XDoes the big pharma monster need taming?https://pharmaphorum.com/views-analysis-sales-marketing/does-the-big-pharma-monster-need-taming/
